Infectious disease
Although many cyber criminals have pledged not to attack healthcare providers during the COVID-19 pandemic, one expert tells CNBC that this may not extend to pharmaceutical companies.
The designation will expedite regulatory review of the medication should it prove to be safe and effective.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 13, 2020.
Gilead stated that the five companies will manufacture the drug for distribution in “low-income and lower-middle-income countries, as well as several upper-middle- and high-income countries.”
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 12, 2020.
Novavax secured the funding from the Coalition for Epidemic Preparedness Innovations to further develop the vaccine candidate as well as support a rapid scale-up of manufacturing to support the vaccine, should it prove to be effective.
A smartphone diagnostic test for COVID-19 being developed by a University of Utah researcher holds the potential for quick, accurate testing without the need for individuals to go to a healthcare facility. A prototype may be ready within two to three months.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.
The new at-home saliva self-collection assay allows for broader screening than the standard and uncomfortable method using nose and throat swabs at a healthcare facility or testing location that requires a physical interaction with a healthcare professional.
A study published by researchers from The Mount Sinai Hospital/Mount Sinai School of Medicine on May 6 revealed that blood thinners may slow down clotting in patients with COVID-19, ultimately improving their chances of survival.
PRESS RELEASES